Tango Therapeutics (TNGX) Net Margin (2020 - 2025)
Tango Therapeutics' (TNGX) quarterly Net Margin came in at 29.52% in Q3 2025, up 28081.0% year-on-year from N/an in Q3 2024, and up 102.42% quarter-over-quarter from 1221.41% in Q2 2025.
Tango Therapeutics (TNGX) Net Margin (2020 - 2025) Analysis & Trends
Tango Therapeutics' Net Margin history runs 6 years deep, the most recent figure standing at 29.52% for Q3 2025.
- On a quarterly basis, Net Margin rose 28081.0% year-over-year to 29.52% in Q3 2025; TTM through Mar 2026 was 188.15%, a 13451.0% increase from a year earlier, with the FY2025 full-year figure at 162.85%, up 14688.0% from the prior year.
- Net Margin improved to 29.52% in Q3 2025 per TNGX's latest filing, from 1221.41% in the prior quarter.
- Across five years, Net Margin topped out at 29.52% in Q3 2025 and bottomed at 1221.41% in Q2 2025.
- The 5-year median for Net Margin is 419.8% (2022), against an average of 412.86%.
- Across the five-year window, Net Margin soared 28862 bps in 2023 and plunged 109285 bps in 2025, its largest moves.
- Year by year, Net Margin stood at 385.69% in 2021, then dropped by 18 bps to 454.0% in 2022, then fell by 25 bps to 565.81% in 2023, then plunged by 62 bps to 914.99% in 2024, then jumped by 103 bps to 29.52% in 2025.
- Per Business Quant, the three latest TNGX Net Margin figures stand at 29.52% (Q3 2025), 1221.41% (Q2 2025), and 739.54% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 29.52% |
| Jun 30, 2025 | -1,221.41% |
| Mar 31, 2025 | -739.54% |
| Dec 31, 2024 | -914.99% |
| Sep 30, 2024 | -251.29% |
| Jun 30, 2024 | -128.56% |
| Mar 31, 2024 | -585.91% |
| Dec 31, 2023 | -565.81% |
| Sep 30, 2023 | -207.45% |
| Jun 30, 2023 | -142.12% |
| Mar 31, 2023 | -485.74% |
| Dec 31, 2022 | -454.00% |
| Sep 30, 2022 | -419.80% |
| Jun 30, 2022 | -430.74% |
| Mar 31, 2022 | -437.79% |
| Dec 31, 2021 | -385.69% |
| Sep 30, 2021 | -288.64% |
| Jun 30, 2021 | -24.75% |
| Mar 31, 2021 | -189.57% |
| Dec 31, 2020 | -1.99% |